We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Colgate-Palmolive (CL) Up 7.6% Since Last Earnings Report: Can It Continue?
Read MoreHide Full Article
A month has gone by since the last earnings report for Colgate-Palmolive (CL - Free Report) . Shares have added about 7.6% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Colgate-Palmolive due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Colgate Q4 Earnings Beat, 2019 View Soft
Colgate-Palmolive delivered better-than-expected top and bottom-line results for fourth-quarter 2018. However, earnings and sales dipped year over year. Unfavorable foreign currency mainly impacted the company’s results. Nonetheless, organic sales benefited from favorable pricing.
Though the company outlined an optimistic view for net sales and organic sales, its earnings per share forecast for 2019 was disappointing.
Adjusted earnings of 74 cents per share in fourth-quarter 2018 dropped 1% from the prior-year quarter number. However, earnings topped the Zacks Consensus Estimate of 73 cents. Including one-time items, earnings were 70 cents per share compared with 37 cents reported in the year-ago period.
Total sales of $3,811 million dipped 2% from the year-ago period but beat the Zacks Consensus Estimate of $3,774 million. The year-over-year decline was mainly driven by negative currency impact of 5%. However, this was somewhat offset by 0.5% growth in global unit volume and 2.5% rise in pricing.
During the reported quarter, Colgate's sales and unit-volume growth benefited from 1% contribution from the recently acquired professional skin care business. On an organic basis, the company’s sales improved 2%.
Deeper Insight
Adjusted gross profit margin of 59.4% contracted 100 basis points (bps) from the prior-year quarter due to increased raw and packaging material expenses. However, this was partly offset by higher pricing and gains from cost savings under the funding-the-growth program.
In the reported quarter, adjusted operating profit of $936 million fell 10% while the adjusted operating margin contracted 210 bps to 24.6%. Operating margin was primarily impacted by lower gross margin, coupled with a 70 bps increase in adjusted selling, general & administrative expenses, as a percentage of sales.
Year to date, Colgate’s market share of manual toothbrushes has reached 32.3%. Further, the company has continued with its leadership in the global toothpaste market, with 42% market share year to date.
Segmental Discussion
North America’s net sales (22% of total sales) improved 5%, reflecting 3% rise in unit volume and 2.5% increase in pricing, offset by currency headwinds of 0.5%. On an organic basis, sales increased 0.5% while unit volume declined 2%.
Latin America’s net sales (23% of total sales) slipped 9% year over year due to 3.5% decrease in unit volume and negative currency impact of 10%. This was partly negated by 4.5% increase in pricing. During the quarter under review, soft volumes in Brazil and Argentina were partly compensated by volume growth Mexico. On an organic basis, sales were up 1%.
Europe’s net sales (16% of total sales) dropped 2.5% year over year due to 1% decline in pricing and 3.5% unfavorable currency exchange, somewhat mitigated by unit volume increase of 2%. Unit volume gained from strength in the U.K. and France. Further, organic sales in Europe rose 1%.
The Asia Pacific’s net sales (16% of total sales) declined 6.5%, attributable to 0.5% decline in both unit volume and pricing as well as 5.5% unfavorable currency exchange. Lower volume in Greater China was somewhat compensated with volume growth in India and Australia. On an organic basis, sales for the Asia Pacific declined 1%.
Africa/Eurasia net sales (6% of total sales) fell 5% year over year, owing to 9% impact from unfavorable currency exchange and 3.5% decline in unit volume. These were offset by 7.5% rise in pricing. Lower volumes in Turkey and South Africa were partly negated by gains in the Gulf States. Organic sales for Africa/Eurasia improved 4%.
Hill’s Pet Nutrition net sales (17% of total sales) rose 6% from the year-ago quarter. Results gained from 3.5% increase in unit volume and 4.5% rise in pricing, offset by 2% negative impact from currency. Volume growth in the United States and Western Europe were negated by the decline in Russia. On an organic basis, sales escalated 8%.
Other Financial Details
Colgate ended 2018 with cash and cash equivalents of $726 million, and total debt of $6,366 million. Net cash provided by operating activities was $3,056 million as of Dec 31, 2018.
Outlook
Going into 2019, Colgate expects strong top-line gains, backed by accelerated investments in its brands, higher pricing and strong innovation. The company’s innovation efforts will be marked by the re-launch of Colgate Total and Hill’s Science Diet as well as expansion of its naturals range.
Driven by these positives, the company expects of flat to up low-single digit in 2019, on current spot rates. Moreover, it estimates organic sales growth of 2-4% for 2019.
Further, the company plans to expand the portfolio by introducing brands like elmex and meridol to newer markets, and extending its e-commerce offerings. It is also likely to increase investments in professional skin care businesses — Elta MD and PCA Skin.
As a result, the company expects gross margin expansion in 2019, both on a GAAP and adjusted basis. On a GAAP basis, earnings per share for 2019 are likely to decline in a low-single digit. Meanwhile, adjusted earnings per share are expected to decline in a mid-single digit. Earnings per share projections are based on higher raw material costs, increase in tax rate, and uncertainties related to the global economy, currency rates and pricing.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates. The consensus estimate has shifted -8.25% due to these changes.
VGM Scores
At this time, Colgate-Palmolive has an average Growth Score of C, a grade with the same score on the momentum front. However, the stock was allocated a grade of F on the value side, putting it in the fifth quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Colgate-Palmolive has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Colgate-Palmolive (CL) Up 7.6% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Colgate-Palmolive (CL - Free Report) . Shares have added about 7.6% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Colgate-Palmolive due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Colgate Q4 Earnings Beat, 2019 View Soft
Colgate-Palmolive delivered better-than-expected top and bottom-line results for fourth-quarter 2018. However, earnings and sales dipped year over year. Unfavorable foreign currency mainly impacted the company’s results. Nonetheless, organic sales benefited from favorable pricing.
Though the company outlined an optimistic view for net sales and organic sales, its earnings per share forecast for 2019 was disappointing.
Adjusted earnings of 74 cents per share in fourth-quarter 2018 dropped 1% from the prior-year quarter number. However, earnings topped the Zacks Consensus Estimate of 73 cents. Including one-time items, earnings were 70 cents per share compared with 37 cents reported in the year-ago period.
Total sales of $3,811 million dipped 2% from the year-ago period but beat the Zacks Consensus Estimate of $3,774 million. The year-over-year decline was mainly driven by negative currency impact of 5%. However, this was somewhat offset by 0.5% growth in global unit volume and 2.5% rise in pricing.
During the reported quarter, Colgate's sales and unit-volume growth benefited from 1% contribution from the recently acquired professional skin care business. On an organic basis, the company’s sales improved 2%.
Deeper Insight
Adjusted gross profit margin of 59.4% contracted 100 basis points (bps) from the prior-year quarter due to increased raw and packaging material expenses. However, this was partly offset by higher pricing and gains from cost savings under the funding-the-growth program.
In the reported quarter, adjusted operating profit of $936 million fell 10% while the adjusted operating margin contracted 210 bps to 24.6%. Operating margin was primarily impacted by lower gross margin, coupled with a 70 bps increase in adjusted selling, general & administrative expenses, as a percentage of sales.
Year to date, Colgate’s market share of manual toothbrushes has reached 32.3%. Further, the company has continued with its leadership in the global toothpaste market, with 42% market share year to date.
Segmental Discussion
North America’s net sales (22% of total sales) improved 5%, reflecting 3% rise in unit volume and 2.5% increase in pricing, offset by currency headwinds of 0.5%. On an organic basis, sales increased 0.5% while unit volume declined 2%.
Latin America’s net sales (23% of total sales) slipped 9% year over year due to 3.5% decrease in unit volume and negative currency impact of 10%. This was partly negated by 4.5% increase in pricing. During the quarter under review, soft volumes in Brazil and Argentina were partly compensated by volume growth Mexico. On an organic basis, sales were up 1%.
Europe’s net sales (16% of total sales) dropped 2.5% year over year due to 1% decline in pricing and 3.5% unfavorable currency exchange, somewhat mitigated by unit volume increase of 2%. Unit volume gained from strength in the U.K. and France. Further, organic sales in Europe rose 1%.
The Asia Pacific’s net sales (16% of total sales) declined 6.5%, attributable to 0.5% decline in both unit volume and pricing as well as 5.5% unfavorable currency exchange. Lower volume in Greater China was somewhat compensated with volume growth in India and Australia. On an organic basis, sales for the Asia Pacific declined 1%.
Africa/Eurasia net sales (6% of total sales) fell 5% year over year, owing to 9% impact from unfavorable currency exchange and 3.5% decline in unit volume. These were offset by 7.5% rise in pricing. Lower volumes in Turkey and South Africa were partly negated by gains in the Gulf States. Organic sales for Africa/Eurasia improved 4%.
Hill’s Pet Nutrition net sales (17% of total sales) rose 6% from the year-ago quarter. Results gained from 3.5% increase in unit volume and 4.5% rise in pricing, offset by 2% negative impact from currency. Volume growth in the United States and Western Europe were negated by the decline in Russia. On an organic basis, sales escalated 8%.
Other Financial Details
Colgate ended 2018 with cash and cash equivalents of $726 million, and total debt of $6,366 million. Net cash provided by operating activities was $3,056 million as of Dec 31, 2018.
Outlook
Going into 2019, Colgate expects strong top-line gains, backed by accelerated investments in its brands, higher pricing and strong innovation. The company’s innovation efforts will be marked by the re-launch of Colgate Total and Hill’s Science Diet as well as expansion of its naturals range.
Driven by these positives, the company expects of flat to up low-single digit in 2019, on current spot rates. Moreover, it estimates organic sales growth of 2-4% for 2019.
Further, the company plans to expand the portfolio by introducing brands like elmex and meridol to newer markets, and extending its e-commerce offerings. It is also likely to increase investments in professional skin care businesses — Elta MD and PCA Skin.
As a result, the company expects gross margin expansion in 2019, both on a GAAP and adjusted basis. On a GAAP basis, earnings per share for 2019 are likely to decline in a low-single digit. Meanwhile, adjusted earnings per share are expected to decline in a mid-single digit. Earnings per share projections are based on higher raw material costs, increase in tax rate, and uncertainties related to the global economy, currency rates and pricing.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates. The consensus estimate has shifted -8.25% due to these changes.
VGM Scores
At this time, Colgate-Palmolive has an average Growth Score of C, a grade with the same score on the momentum front. However, the stock was allocated a grade of F on the value side, putting it in the fifth quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Colgate-Palmolive has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.